SCHEMBL26259451

SCHEMBL26259451

COc1cc(-c2nccs2)c2ccccc2c1-c1nccs1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMPD3 Q9NY59 1/20 0.47
TUBB4A P04350 4/20 0.46
TUBB P07437 4/20 0.46
TUBA3C P0DPH7 4/20 0.46
TUBA1B P68363 4/20 0.46
TUBA4A P68366 4/20 0.46
TUBB4B P68371 4/20 0.46
TUBB3 Q13509 4/20 0.46
TUBB2A Q13885 4/20 0.46
TUBB8 Q3ZCM7 4/20 0.46
TUBA3E Q6PEY2 4/20 0.46
TUBA1A Q71U36 4/20 0.46
TUBA1C Q9BQE3 4/20 0.46
TUBB6 Q9BUF5 4/20 0.46
TUBB2B Q9BVA1 4/20 0.46
TUBB1 Q9H4B7 4/20 0.46
PDPK1 O15530 1/20 0.41
BDKRB2 P30411 1/20 0.41
ECE1 P42892 1/20 0.40
S1PR1 P21453 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26259500 0.86 PDE4A (0.43) SMPD3TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL26259608 0.84 SMPD3 (0.42) SMPD3TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL26259637 0.81 SMPD3 (0.50) SMPD3TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL26259390 0.80 PDPK1 (0.44) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL26259281 0.79 MAPT (0.60) SMPD3TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL29715238 0.78 ADRA1D (0.52) SMPD3TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL5396495 0.78 ADRA1D (0.52) SMPD3TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL26259522 0.77 PDPK1 (0.41) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL26259375 0.73 PDPK1 (0.59) PDPK1ADRA1DADRA1AADRA1BNPC1
SCHEMBL26259909 0.71 SMPD3 (0.54) SMPD3TUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND NUDC, CCNL2, SPIN3 SMPD3 3548/4885TUBB4A 360/4885TUBB 651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.